Friday, January 9, 2026
HomePharma

Pharma

Pharma

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

Life Sciences Times - 0
Pharma

AstraZeneca’s IMFINZI Gets First U.S. Approval for Perioperative Use in Early Gastric and GEJ Cancers

Life Sciences Times - 0
Pharma

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

Life Sciences Times - 0
Pharma

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

Life Sciences Times - 0
Pharma

PharmaEssentia Highlights Publication of Phase 3 SURPASS-ET Trial Results in The Lancet Haematology

Life Sciences Times - 0
Pharma

FDA Approves Promega OncoMate MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA and LENVIMA in Advanced Endometrial Carcinoma

Life Sciences Times - 0
Pharma

City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant

Life Sciences Times - 0
Pharma

AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome

Life Sciences Times - 0
Pharma

Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart

Life Sciences Times - 0
Pharma

Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis

Life Sciences Times - 0
Pharma

Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration

Life Sciences Times - 0
Pharma

Corsera Health Files First Phase 1 Clinical Trial Application for Preventive RNAi Medicine Targeting Cardiovascular Disease

Life Sciences Times - 0
1234...86Page 3 of 86

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv